2024
Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity
Network A, Sangchooli A, Zare-Bidoky M, Jouzdani A, Schacht J, Bjork J, Claus E, Prisciandaro J, Wilson S, Wüstenberg T, Potvin S, Ahmadi P, Bach P, Baldacchino A, Beck A, Brady K, Brewer J, Childress A, Courtney K, Ebrahimi M, Filbey F, Garavan H, Ghahremani D, Goldstein R, Goudriaan A, Grodin E, Hanlon C, Haugg A, Heilig M, Heinz A, Holczer A, Van Holst R, Joseph J, Juliano A, Kaufman M, Kiefer F, Zonoozi A, Kuplicki R, Leyton M, London E, Mackey S, McClernon F, Mellick W, Morley K, Noori H, Oghabian M, Oliver J, Owens M, Paulus M, Perini I, Rafei P, Ray L, Sinha R, Smolka M, Soleimani G, Spanagel R, Steele V, Tapert S, Vollstädt-Klein S, Wetherill R, Witkiewitz K, Yuan K, Zhang X, Verdejo-Garcia A, Potenza M, Janes A, Kober H, Zilverstand A, Ekhtiari H. Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity. JAMA Psychiatry 2024, 81: 414-425. PMID: 38324323, PMCID: PMC11304510, DOI: 10.1001/jamapsychiatry.2023.5483.Peer-Reviewed Original ResearchTreatment developmentNeurobiology of drug addictionDrug cue reactivitySubstance use disordersBiomarkers of addictionCue reactivityAddictive disordersBiomarker developmentDrug addictionTreatment responseTreatment outcomesVisual cuesTask designCore aspectsAddictionClinical judgmentParticipant characteristicsDisordersOutcome predictorsClinical useMEDLINE databaseBiomarker qualificationSeveral biomarkersTranslational gapDatabase inception
2023
A systematic review and meta-analysis of neuromodulation therapies for substance use disorders
Mehta D, Praecht A, Ward H, Sanches M, Sorkhou M, Tang V, Steele V, Hanlon C, George T. A systematic review and meta-analysis of neuromodulation therapies for substance use disorders. Neuropsychopharmacology 2023, 49: 649-680. PMID: 38086901, PMCID: PMC10876556, DOI: 10.1038/s41386-023-01776-0.Peer-Reviewed Original ResearchRepetitive transcranial magnetic stimulationTranscranial direct current stimulationSubstance use disordersDeep brain stimulationDorsolateral prefrontal cortexUse disordersEffects of rTMSTreatment of SUDsSubstance useLong-term outcomesLeft dorsolateral prefrontal cortexTranscranial magnetic stimulationSystematic literature searchDirect current stimulationEffect sizeSubstance use outcomesAddiction neurocircuitryUncontrolled studiesDBS studiesNeuromodulation therapiesMagnetic stimulationPsychosocial treatmentsBrain stimulationTreatment durationAdministration protocol
2022
Characterizing Impulsivity in Individuals with Heroin Use Disorder
Kang T, Zhang Y, Zhao J, Li X, Jiang H, Niu X, Xie R, Ding X, Steele V, Yuan T. Characterizing Impulsivity in Individuals with Heroin Use Disorder. International Journal Of Mental Health And Addiction 2022, 22: 1530-1545. DOI: 10.1007/s11469-022-00941-8.Peer-Reviewed Original ResearchHeroin use disorderHealthy controlsUse disordersClinical severityMale healthy controlsSubstance use disordersDaily dosageRehabilitation hospitalFormer groupBIS-11 scoresMale participantsDisordersMale individualsSeverityParticipantsImpulsivityScoresTotal net scoreCognitive impulsivityGroupHospitalIGTIndividualsHow an Exemplar of Chronic Neuromodulation for Cocaine Use Disorder is a Path Forward for Treating Substance Use Disorders
Steele V. How an Exemplar of Chronic Neuromodulation for Cocaine Use Disorder is a Path Forward for Treating Substance Use Disorders. Biological Psychiatry 2022, 91: s37. DOI: 10.1016/j.biopsych.2022.02.110.Peer-Reviewed Original Research
2021
Response Inhibition Circuit Dysregulation in Substance Use Disorders Identified With Event-Related Potential-Derived Functional Connectivity
Steele V, Tootell A, Butler D, Fix S, Stevens M, Pearlson G, Bernat E. Response Inhibition Circuit Dysregulation in Substance Use Disorders Identified With Event-Related Potential-Derived Functional Connectivity. Biological Psychiatry 2021, 89: s350. DOI: 10.1016/j.biopsych.2021.02.873.Peer-Reviewed Original ResearchSubstance use disordersCircuit dysregulationUse disordersFunctional connectivityEvent-related potentials
2019
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead
Ekhtiari H, Tavakoli H, Addolorato G, Baeken C, Bonci A, Campanella S, Castelo-Branco L, Challet-Bouju G, Clark VP, Claus E, Dannon PN, Del Felice A, den Uyl T, Diana M, di Giannantonio M, Fedota JR, Fitzgerald P, Gallimberti L, Grall-Bronnec M, Herremans SC, Herrmann MJ, Jamil A, Khedr E, Kouimtsidis C, Kozak K, Krupitsky E, Lamm C, Lechner WV, Madeo G, Malmir N, Martinotti G, McDonald W, Montemitro C, Nakamura-Palacios EM, Nasehi M, Noël X, Nosratabadi M, Paulus M, Pettorruso M, Pradhan B, Praharaj SK, Rafferty H, Sahlem G, Salmeron BJ, Sauvaget A, Schluter RS, Sergiou C, Shahbabaie A, Sheffer C, Spagnolo PA, Steele VR, Yuan TF, van Dongen J, Van Waes V, Venkatasubramanian G, Verdejo-García A, Verveer I, Welsh J, Wesley MJ, Witkiewitz K, Yavari F, Zarrindast MR, Zawertailo L, Zhang X, Cha YH, George TP, Frohlich F, Goudriaan AE, Fecteau S, Daughters SB, Stein EA, Fregni F, Nitsche MA, Zangen A, Bikson M, Hanlon CA. Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead. Neuroscience & Biobehavioral Reviews 2019, 104: 118-140. PMID: 31271802, PMCID: PMC7293143, DOI: 10.1016/j.neubiorev.2019.06.007.Peer-Reviewed Original ResearchConceptsSubstance use disordersNon-invasive brain stimulationConsensus paperAddiction medicineNovel treatment optionsMental health disordersTranscranial magnetic stimulationRecent FDA approvalHeterogeneity of methodsNIBS treatmentTreatment optionsFuture therapiesMagnetic stimulationBrain stimulationPreclinical neuroscienceClinical practiceHealth disordersFDA approvalNeural circuitsNeuromodulation toolBasic neuroscienceSUD researchStimulationSystematic literature reviewDisordersChapter 6 Addiction: Informing drug abuse interventions with brain networks
Steele V, Ding X, Ross T. Chapter 6 Addiction: Informing drug abuse interventions with brain networks. 2019, 101-122. DOI: 10.1016/b978-0-12-813838-0.00006-6.ChaptersSubstance use disordersBrain networksNoninvasive brain stimulationDefault mode networkExecutive control networkRisk factorsEffective treatmentBrain stimulationUse disordersClinical modelBrain diseasesDiseaseEffective interventionsNew targetsInterventionAbuse interventionsReward processingFocal manipulation